NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-135-2019-0-IN-09 T CELL RECEPTORS RECOGNIZING R175H OR Y220C MUTATION IN P53 IN National Stage 202247003029 Pending
NHGRI E-104-2019-0-EP-03 SYNTHETIC GENES FOR THE TREATMENT OF PROPIONIC ACIDEMIA CAUSED BY MUTATIONS IN PROPIONYL-COA CARBOLXYLASE ALPHA EP National Stage 20743021.6 Pending
NIAID E-045-2015-0-HK-11 Neutralizing Antibodies to Ebola Virus Glycoprotein and Their Use HK EP 42022046399.6 Pending
NCI E-174-2018-2-AU-16 CAS9 Modified TILS For Treatment Of Gastrointestinal Cancer AU DIV 2022200267 Pending
NIAID E-055-2021-0-PCT-02 Replication-Competent Adenovirus Type 4-SARS-CoV-2 Vaccines And Their Use PCT PCT PCT/US2022/012530 Expired
NCI E-063-2017-0-US-08 Denoising of Synamic Magnetic Resonance Spectroscopic Imaging Using Low Rank Approximations in the Kinetic Domain US CON 17/576,283 Pending
NIDCD E-004-2019-1-HK-08 ADENO-ASSOCIATED VIRUSES AND THEIR USES FOR INNER EAR THERAPY HK EP 62022046132.6 Pending
NIDCD E-004-2019-0-HK-06 ADENO-ASSOCIATED VIRUSES AND THEIR USES FOR INNER EAR THERAPY HK EP 62022046131.8 Pending
NCI E-135-2019-0-ZA-14 T CELL RECEPTORS RECOGNIZING R175H OR Y220C MUTATION IN P53 ZA National Stage 2022/00598 Pending
NCATS E-244-2014-0-US-32 SMALL MOLECULE INHIBITORS OF LACTATE DEHYDROGENASE AND METHODS OF USE THEREOF US CON 17/572,359 11897845 Issued PDF
NCI E-014-2017-0-US-07 HUMAN MONOCLONAL ANTIBODIES SPECIFIC FOR FLT3 AND USES THEREOF US DIV 17/570,248 Pending
NCI E-135-2019-0-AU-04 T CELL RECEPTORS RECOGNIZING R175H OR Y220C MUTATION IN P53 AU National Stage 2020308004 Pending
NIBIB E-237-2020-0-PCT-02 Producing Isotropic Super-Resolution Images From Line Scanning Confocal Microscopy PCT PCT PCT/US2022/011484 Expired
NIDDK E-051-2021-0-PCT-01 HETEROCYCLIC P2Y14 RECEPTOR ANTAGONISTS PCT PCT COMB PCT/US2022/011226 Expired
NHGRI E-044-2013-1-JP-19 OLIGONUCLEOTIDE ANALOGUES TARGETING HUMAN LMNA JP DIV 2022-000125 Pending
NCATS E-262-2016-0-US-06 COMPOUNDS, COMPOSITIONS, METHODS FOR TREATING DISEASES, AND METHODS FOR PREPARING COMPOUNDS US CON 17/568,023 Pending
NIAID E-134-2020-1-PCT-01 Antibody-guided PCSK9 Immunogens Lacking 9-residue Sequence Overlap With Human Proteins PCT PCT COMB PCT/US2021/065856 Expired
NCI E-042-2014-0-JP-32 Chimeric Antigen Receptors Targeting CD-19 JP DIV 2021-215427 Pending
NHLBI E-186-2014-1-JP-16 SUPERAGONISTS, PARTIAL AGONISTS AND ANTAGONISTS OF INTERLEUKIN-2 JP DIV 2021-213818 Pending
NCI E-103-2019-0-US-07 MONOCLONAL ANTIBODIES THAT BIND EGFRVIII AND THEIR USE US National Stage 17/623,370 Pending
NIDDK E-138-2017-0-IL-18 COMPOUNDS AND METHODS FOR TREATING NEUROLOGICAL AND CARDIOVASCULAR CONDITIONS IL DIV 289423 Pending
NCI E-135-2019-0-CN-07 T CELL RECEPTORS RECOGNIZING R175H OR Y220C MUTATION IN P53 CN National Stage 202080047882.0 Pending
NCI E-135-2019-0-JP-10 T CELL RECEPTORS RECOGNIZING R175H OR Y220C MUTATION IN P53 JP National Stage 2021-576970 Pending
NCI E-135-2019-0-BR-05 T CELL RECEPTORS RECOGNIZING R175H OR Y220C MUTATION IN P53 BR National Stage BR112021026408-6 Pending
NCI E-171-2020-0-PCT-02 EXO VII Inhibitor and Quinolone Antibiotic
Combination Useful for Treating Bacterial Infection 		PCT PCT PCT/US2021/064996 Expired
NCI E-022-2017-0-EP-05 METHODS FOR SELECTING THERAPY FOR A CANCER PATIENT EP DIV 21217161.5 Abandoned
NICHD E-210-2021-0-US-02 Kits And Methods For Predictions And Treatment Of Preeclampsia US CON 17/558,248 11782065 Issued PDF
NCI E-042-2014-0-US-31 CHIMERIC ANTIGEN RECEPTORS TARGETING CD-19 US CON 17/557,845 Pending
NCI E-257-2009-1-US-25 Use Of IL-15 To Increase Thymic Output US DIV 17/558,365 Abandoned
NIAID E-086-2018-3-EP-04 Zika Viral Antigen Constructs EP DIV 21216477.6 Pending
Leidos E-039-2017-0-US-05 METHODS OF TREATMENT USING PHENYL INDOLE ALLOSTERIC INHIBITORS OF P97 ATPASE US CON 17/556,147 Pending
NCI E-135-2019-0-US-16 T CELL RECEPTORS RECOGNIZING R175H OR Y220C MUTATION IN P53 US National Stage 17/620,942 Pending
NCI E-205-2016-0-US-06 NANOPARTICLE TO TARGET CANCER US DIV 17/555,285 11696922 Issued PDF
NEI E-013-2021-0-PCT-02 COMPOSITION AND METHOD OF PRESERVING VIABILITY OF CELL IN A LOW TEMPERATURE PCT PCT PCT/US2021/064086 Expired
NEI E-070-2019-0-US-07 INTERLEUKIN-27 PRODUCING B-CELLS AND USES THEREOF US National Stage 17/620,248 Pending
NHGRI E-104-2019-0-US-04 SYNTHETIC GENES FOR THE TREATMENT OF PROPIONIC ACIDEMIA CAUSED BY
MUTATIONS IN PROPIONYL-COA CARBOXYLASE ALPHA 		US National Stage 17/620,331 Pending
NIAID E-001-2017-1-US-04 ANTIBODIES AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF EPSTEIN BARR VIRUS INFECTION US DIV 17/553,139 11926656 Issued PDF
NCI E-176-2014-0-JP-63 ANTI-HUMAN PAPILLOMAVIRUS 16 E7 T CELL RECEPTORS JP DIV 2021-203953 Issued
NHGRI E-034-2019-0-HK-17 NON-DISRUPTIVE GENE THERAPY FOR THE TREATMENT OF MMA HK CN 62021044683.2 Pending
NCI E-135-2019-0-MX-11 T CELL RECEPTORS RECOGNIZING R175H OR Y220C MUTATION IN P53 MX National Stage MX/a/2021/015877 Pending
NCI E-135-2019-0-CA-06 T CELL RECEPTORS RECOGNIZING R175H OR Y220C MUTATION IN P53 CA National Stage 3144070 Pending
NIAID E-024-2021-0-PCT-02 DNA VECTOR AND USES THEREOF FOR DETECTING HIV AND SIV PCT PCT PCT/US2021/063514 Expired
NIAID E-030-2021-0-PCT-02 HUMAN MONOCLONAL ANTIBODIES TARGETING SARS-COV-2 PCT PCT PCT/US2021/063525 Expired
NCI E-135-2019-0-SG-13 T CELL RECEPTORS RECOGNIZING R175H OR Y220C MUTATION IN P53 SG National Stage 11202113949V Pending
NIAID E-007-2015-0-US-36 CD47-targeted Therapies For The Treatment Of Infectious Disease US CON 17/550,881 11780931 Issued PDF
NIAID E-133-2015-0-US-11 NEUTRALIZING ANTIBODIES TO HIV-1 GP41 AND THEIR USE US CON 17/551,066 Pending
NCI E-147-2021-0-PCT-02 COMPOSITIONS AND METHODS FOR TREATING CANCER PCT PCT PCT/US2021/062832 Expired
NCI E-175-2016-0-JP-18 ANTI-KRAS-G12D T CELL RECEPTORS JP DIV 2021-199878 Issued
NINDS E-198-2021-0-PC-02 Therapeutics for the Treatment of Neurodegenerative Disorders PCT PCT PCT/EP2021/084908 Expired
NINDS E-071-2023-0-GB-01 Therapeutics for the Treatment of Neurodegenerative Disorders GB ORD 2117758.9 Pending